Subsidiary13 Apr 2026, 03:38 pm
Alkem Labs incorporates wholly-owned subsidiary in Dubai for AED 3.67M
AI Summary
Alkem Laboratories Ltd has incorporated a new Wholly Owned Subsidiary (WOS) named ‘Alkem Pharma Trading FZCO’ in Dubai, UAE. The subsidiary has an Authorized and Subscribed Share Capital of AED 3,670,000, divided into 367,000 Equity Shares of AED 10 each. The primary objective of Alkem Pharma Trading FZCO is to facilitate the export of Alkem Laboratories' products to African, South East Asian, and non-UAE markets, thereby expanding the company's international reach. This strategic move aims to strengthen Alkem's presence in key emerging markets. The incorporation was completed on March 27, 2026, with Alkem Laboratories acquiring 100% shareholding for a cash consideration.
Key Highlights
- Alkem Labs incorporated a wholly-owned subsidiary in Dubai, UAE.
- The new WOS, Alkem Pharma Trading FZCO, has AED 3.67M capital.
- It will export Alkem's products to African, SE Asian, and non-UAE markets.
- This expands Alkem's global market reach and sales potential.
- Alkem Laboratories holds 100% equity in the new entity.